Home > Insider Trading > Filing (0001596771-19-000026)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1610092	Diplomat Pharmacy Inc.	DPLO	Retail-Drug Stores And Proprietary Stores (5912)	382063100

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1703619	Atul Kavthekar	4100 S. Saginaw Street Flint MI 48507	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-03-18	15,118	$0.00	28,218	No	4	A	Direct
Common Stock	Disposition	2019-03-19	1,265	$5.84	26,953	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

On March 27, 2018, Mr. Kavthekar was granted restricted stock units that were subject to the issuer's satisfaction of certain financial performance criteria. On March 18, 2019 (the "determination date"), the performance criteria was met with respect to 15,118 restricted stock units. One-third of the restricted stock units vested upon the determination date, and the remaining two-thirds will vest in two equal installments on each anniversary of the determination date, subject to continued employment.
The sales reported in this Form 4 represent shares sold to cover the tax liability incurred incident to the delivery of shares of common stock from the previously awarded restricted stock units.
The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $5.80 to $5.8525 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.